Thalassemia Market Is Expected to Generate USD 4.2 Billion by 2031: Allied Market Research

Growth & innovations in the pharmaceutical industry for the manufacturing of thalassemia drugs owing to massive pool of health conscious consumers serve as potential opportunities for the expansion of the global thalassemia market. Based on region, North America held the largest share in 2021, contributing to nearly half of the global thalassemia market share.


Portland, OR, Jan. 11, 2023 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global thalassemia market garnered $2.5 billion in 2021, and is estimated to generate $4.2 billion by 2031, manifesting a CAGR of 5.0% from 2022 to 2031. The report provides an extensive analysis of changing market dynamics, major segments, value chain, competitive scenario, and regional landscape. This research offers a valuable guidance to leading players, investors, shareholders, and startups in devising strategies for the sustainable growth and gaining competitive edge in the market.

Download Free Sample Report- https://www.alliedmarketresearch.com/request-sample/15812

Report coverage & details:

Report Coverage Details
Forecast Period 2022­–2031
Base Year 2021
Market Size in 2021 $2.5 billion
Market Size in 2031 $4.2 billion
CAGR 5.0%
No. of Pages in Report 215
Segments covered treatment, type, distribution channel, and region.
Drivers Surge in demand for enhanced healthcare services,

Significant investments by government to improve healthcare infrastructure,

Development of the medical tourism industry in emerging countries
Opportunities Growth & innovations in the pharmaceutical industry for the manufacturing of thalassemia drugs owing to massive pool of health conscious consumers
Restraints High cost of gene therapy owing to their specialized raw material and manufacturing processes


Covid-19 Scenario:

  • The outbreak of COVID-19 had disrupted workflows in the health care sector around the world. The thalassemia market experienced a decline in 2021, due to global economic recession led by COVID-19.
  • In addition, the COVID-19 outbreak disrupted the supply chain of thalassemia drugs across various end-user industries like hospitals and pharmacies.
  • However, the market is anticipated to witness recovery in 2021, and show stable growth in the coming future. This is attributed to the increase in adoption of various screening techniques during pregnancy for genetic abnormalities and proper counselling regarding thalassemia.

The research provides detailed segmentation of the global thalassemia market based on treatment, type, distribution channel, and region. The report discusses segments and their sub-segments in detail with the help of tables and figures. Market players and investors can strategize according to the highest revenue-generating and fastest-growing segments mentioned in the report.

Based on treatment, the iron chelation therapy segment held the highest share in 2021, accounting for more than half of the global thalassemia market, and is expected to continue its leadership status during the forecast period. However, the others segment is expected to register the highest CAGR of 5.5% from 2022 to 2031.

For Purchase Inquiry- https://www.alliedmarketresearch.com/purchase-enquiry/15812

Based on type, the alpha thalassemia segment accounted for the highest share in 2021, contributing to  more than three-fourths of the global thalassemia market, and is expected to maintain its lead in terms of revenue during the forecast period. This segment is expected to manifest the highest CAGR of 5.4% from 2022 to 2031.

Based on distribution channel, the drug stores and retail pharmacies segment accounted for the highest share in 2021, holding more than half of the global thalassemia market, and is expected to continue its leadership status during the forecast period. However, the online providers segment is estimated to grow at the highest CAGR of 6.7% during the forecast period.

Based on region, North America held the largest share in 2021, contributing to nearly half of the global thalassemia market share, and is projected to maintain its dominant share in terms of revenue in 2031. In addition, the Asia-Pacific region is expected to manifest the fastest CAGR of 6.8% during the forecast period.

Leading market players of the global thalassemia market analyzed in the research include FRESENIUS SE & Co. KGaA (Fresenius Kabi), Apotex Inc, Novartis AG, Pfizer Inc., Sun Pharmaceutical Industries Limited, Alvogen Inc, Bluebirdbio, Bristol Myers Squibb Co., Chiesi Farmaceutici S.p.A, Cipla Ltd.

The report provides a detailed analysis of these key players of the global thalassemia market. These players have adopted different strategies such as new product launches, collaborations, expansion, joint ventures, agreements, and others to increase their market share and maintain dominant shares in different regions. The report is valuable in highlighting business performance, operating segments, product portfolio, and strategic moves of market players to showcase the competitive scenario. 

Trending Reports in Healthcare Industry:

Biomarkers Market - Global Opportunity Analysis and Industry Forecast, 2020–2030

Male Infertility Market - Global Opportunity Analysis and Industry Forecast, 2020-2030

Biosimilars Market - Global Opportunity Analysis and Industry Forecast, 2020-2030

Synthetic Biology Market- Global Opportunity Analysis and Industry Forecast, 2020–2030

Medical/Diagnostic Imaging Market - Global Opportunity Analysis and Industry Forecast, 2020–2030

Dialysis Market- Global Opportunity Analysis and Industry Forecast, 2020–2030

AVENUE- A Subscription-Based Library (Premium on-demand, subscription-based pricing model) Offered by Allied Market Research:

AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.

Get an access to the library of reports at any time from any device and anywhere. For more details, follow the link: https://www.alliedmarketresearch.com/library-access

“We have also published few syndicated market studies in the similar area that might be of your interest. Below are the report title for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market.”

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact
David Correa

5933 NE Win Sivers Drive
#205, Portland, OR 97220                                                               
United States
Toll Free: +1-800-792-5285                                                             
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com 
Web: https://www.alliedmarketresearch.com  

Follow Us on: LinkedIn Twitter